Skip to main content

Concord Wealth Partners

Position in NVS — Novartis AG

CIK 1814214 ABINGDON, VA

Position in NVS

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$198,094
+$20,656 QoQ
Shares Held
1,264
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,322
of 1,603 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $18,338,750 across 12 Drug Manufacturers - General names. NVS ranks #8 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
1,264 $198,094

All Filings in NVS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $198,094 1,264
2025-12-31 $177,438 1,287
2025-09-30 $165,044 1,287
2025-06-30 $193,131 1,596
2025-03-31 $147,822 1,326
2024-12-31 $136,039 1,398
2024-09-30 $196,109 1,705
2024-06-30 $219,839 2,065
2024-03-31 $243,566 2,518
2023-12-31 $196,083 1,942
2023-09-30 $326,257 3,203
2023-06-30 $324,526 3,216
2023-03-31 $278,116 3,023
2022-12-31 $313,256 3,453
2022-09-30 $297,199 3,910
2022-06-30 $322,904 3,820
2022-03-31 $483,239 5,507
2021-12-31 $473,387 5,412
2021-09-30 $122,015 1,492
2021-06-30 $310,489 3,403
2021-03-31 $231,565 2,709
2020-12-31 $167,990 1,779